Important notification
23.12.2016
23.12.2016
21.12.2016 To the attention of interested persons EMA press release on direct-acting antivirals for hepatitis C: EMA confirms recommendation to […]
21.12.2016 To the attention of interested persons EMA press release on start of a review concerning the conduct of studies […]
08.12.2016 To the attention of interested persons The National Agency for Medicines and Medical Devices (NAMMD) would like to announce […]
08.12.2016 To the attention of interested persons The National Agency for Medicines and Medical Devices (NAMMD) would like to announce […]
08.12.2016 To the attention of interested persons EMA press release: PRAC warns of risk of hepatitis B re-activation with direct-acting […]
29.11.2016 To the attention of interested persons Please be informed that the NAMMD is not working with the public during […]
20.10.2016 To the attention of interested persons Press release: EMA recommends measures to ensure safe use of Keppra oral solution […]
19.10.2016 To the attention of interested persons EMA press release: Use of metformin to treat diabetes now expanded to patients […]
17.10.2016 To the attention of interested persons The National Agency for Medicines and Medical Devices (NAMMD) has concluded the assessment […]